H.R. 1476: PLASMA Act

H.R. 1476 is a federal bill in the 119th Congress. Currently, manufacturers of prescription drugs covered by Medicare must provide a 10% discount during the initial coverage phase and a 20% discount during the catastrophic coverage phase. This bill changes that for plasma-derived products. Instead of the… See its sponsors, how members voted, and a plain-English breakdown on PolityLens.